New Classification for Chronic Pain

The World Health Organization (WHO) has updated the International Classification of Diseases (ICD-11). For the first time, they have included chronic pain and provided specific pain diagnoses. Under the new system, chronic pain is classified as either chronic primary pain or chronic s
Continue Reading →

Cannabis and Chronic Pain

  NICE guidance on cannabis-based medicines out for consultation   The National Institute for Health and Care Excellence (NICE) has issued draft guidance for the use of cannabis-based medicines considering the evidence for their use in intractable nausea and vomiting; chroni
Continue Reading →

September is Pain Awareness Month!

  The World Health Assembly (WHA) – a subsection of the World Health Organization (WHO) – has declared September Pain Awareness Month. This month is dedicated to raising public awareness and understanding of pain. Many organisations around the world contribute, including the U.S.
Continue Reading →

IASP Global Year against Pain in the Most Vulnerable

The International Association for the Study of Pain (IASP) has made 2019 their ‘Global Year against Pain in the Most Vulnerable’. The groups included in IASP’s Global Year against Pain in the Most Vulnerable are: older persons (including pain in dementia), infants and young children,
Continue Reading →

Pain Matters is now available on your computer, tablet or phone

We are delighted to announce the return of our digital version of Pain Matters Pain Matters, the magazine for people living with chronic pain, is now available digitally! You can order the latest edition and all previous edition back to issue 48 now. Subscribe quarterly or annually, o
Continue Reading →

Reclassification of Pregabalin and Gabapentin

As mentioned in the Latest News post of 17th October 2018 – and also featured in the forthcoming issue, issue 71, of Pain Matters – as of 1st April 2019, prescription drugs Pregabalin and Gabapentin are to be reclassified as Class C controlled substances. NHS England has j
Continue Reading →

Opioid Epidemic

A recent article on the academic and current affairs website, The Conversation, by Professor Blair Smith from the University of Dundee, regarding his team’s study on the global increase in opioid use, has sparked debate over the overprescription of opioids in the UK. Professor Smith h
Continue Reading →

New study – Cannabinoids and chronic non-cancer pain conditions

Cannabis and Chronic Pain by John Finch The journal Pain recently published an important study on the use of cannabis, and medicines based on cannabis (cannabinoids), for chronic pain conditions (chronic pain in cancer patients was specifically excluded). Researchers were from institu
Continue Reading →

Government announcement: Pregabalin and gabapentin to be controlled as class C drugs

Full text: “Prescription drugs pregabalin and gabapentin are to be reclassified as class C controlled substances from next April, the government announced today (15 October). Prescription drugs pregabalin and gabapentin are to be reclassified as class C controlled substances fro
Continue Reading →

Promo for Pain Concern’s Navigator Tool

New research from Pain Concern offers the prospect of better care for those living with chronic pain. The specially-developed ‘Navigator Tool’ encourages positive communication between people seeking to manage debilitating pain and their healthcare professionals. Expect mo
Continue Reading →
https://www.shoesfindoutlet.co/